发明名称 NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
摘要 The invention provides isolated nucleic acids molecules, designated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203 or 16852 gene has been introduced or disrupted. The invention still further provides isolated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 proteins, fusion proteins, antigenic peptides and anti-15571, 2465, 14266, 2882, 52871, 8203 or 16852 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
申请公布号 US2011171205(A1) 申请公布日期 2011.07.14
申请号 US201113012890 申请日期 2011.01.25
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 HODGE MARTIN R.;LLOYD CLARE M.;WEICH NADINE S.;LORA JOSE M.;WHITE DAVID;GLUCKSMANN MARIA A.;ROBISON KEITH E.;SILOS-SANTIAGO INMACULADA;GOODEARL ANDREW D.J.;CURTIS RORY A.J.
分类号 A61K39/395;A61K31/7088;A61K38/17;A61P3/10;A61P9/00;A61P9/04;A61P15/02;A61P19/02;A61P25/00;A61P25/16;A61P25/18;A61P25/28;A61P35/00;C07H21/04;C07K14/00;C07K16/18;C12N1/21;C12N5/00;C12N15/11;C12P21/02;C12Q1/68;G01N33/53 主分类号 A61K39/395
代理机构 代理人
主权项
地址